Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
International Rectifier Corporation (IRF)
F2Q 2013 Earnings Conference Call
January 28, 2013 17:00 ET
Chris Toth - Investor Relations
Oleg Khaykin - Chief Executive Officer
Ilan Daskal - Chief Financial Officer
Amit Chanda - Wells Fargo
Alex Gauna - JMP Securities
Terence Whalen - Citi
Craig Berger - FBR Capital Markets
Stephen Chin - UBS
James Schneider - Goldman Sachs
Steve Smigie - Raymond James
Previous Statements by IRF
» International Rectifier's CEO Discusses F1Q13 Results - Earnings Call Transcript
» International Rectifier's CEO Presents at Citi Technology Conference (Transcript)
» International Rectifier Corporation's CEO Discusses Fourth Quarter Results - Earnings Call Transcript
» International Rectifier's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Mr. Chris Toth, you may begin your call.
Thank you, operator. Hello and good afternoon. We all welcome you to the International Rectifier conference call. On the call today are Chief Executive Officer, Oleg Khaykin and Chief Financial Officer, Ilan Daskal. I trust you’ve all seen copies of our press release, which was published about an hour ago. If not, the press release can be found on our website at investor.irf.com in the Investor Relations section.
Before we begin, I would like to remind you that except for historical information the matters that we will be describing this afternoon will be forward-looking statements that are dependent upon certain risks and uncertainties, including factors such as orders shipped and received during the quarter, the timing and introduction of new technologies and products, general semiconductor industry conditions, and the overall economy and financial markets. In addition to these risks, we refer you to the risk factors included in our press release that we issued about an hour ago and in our most recent SEC filings.
I would also like to mention that in addition to reporting our GAAP financial results, we are presenting supplemental non-GAAP financial data. A reconciliation of the non-GAAP to GAAP measures set out in our release and discussion today can be found on the website and in our press release. We believe providing non-GAAP measures combined with our GAAP results provides a more meaningful representation regarding the company’s operational performance. Our non-GAAP presentation and EPS calculations exclude certain items such as accelerated depreciation, restructuring and severance charges, amortization of acquisition-related intangibles, and certain discrete tax items, among others.
Lastly, I would like to highlight the following upcoming events. On Wednesday, February 13, we will be attending the 2013 Goldman Sachs Technology Conference in San Francisco; Tuesday, February 26, we will be attending the UBS Small-Mid Cap One-on-One Symposium in Boston; and Wednesday, February 27, we will be attending the Morgan Stanley Technology Conference in San Francisco.
Now, Ilan will discuss our most recent financials. Ilan?
Thank you, Chris. Good afternoon and thank you all for joining us. For the second quarter of fiscal 2013, IR reported a revenue of $223.8 million, which was 11.4% decrease from the prior quarter and a 2.7% decrease from the year ago quarter.
Gross margin on a GAAP basis was 21.9%. Non-GAAP gross margin was 22.2% and excluded $551,000 of accelerated depreciation primarily associated with the closure of our El Segundo facility. The gross margin decline from the prior quarter was primarily due to absorption and underutilization as we significantly reduced inventory in the quarter. Overall, the GAAP net loss was $32.7 million or $0.47 per share for the quarter. This compares with a GAAP net loss of $28.8 million, or $0.42 per share in the prior quarter, and a GAAP net loss of $6.3 million, or $0.09 per share in the prior year quarter.
Non-GAAP net loss was $30.3 million or $0.44 per share for the quarter. The non-GAAP net loss excluded $551,000 of accelerated depreciation, $4.9 million of asset impairment, restructuring and other charges, amortization of intangibles of $1.7 million, and a net tax benefit of $4.7 million. This compares with a non-GAAP net loss of $13.9 million or $0.20 per share in the September quarter, and a non-GAAP net loss of $2.9 million or $0.04 per share in the December quarter of last year.
Moving on to operating expenses, for the December quarter R&D expenses declined to $32.1 million, which represented 14.4% of revenue. SG&A expenses declined to $45.1 million and represented 20.1% of revenue. The reduction in SG&A and R&D expenses from the prior quarter was a result of actions to reduce cost. Amortization of acquisition-related intangibles was $1.7 million.
During the quarter we recorded $4.9 million in asset impairment restructuring and other charges. GAAP tax for the quarter was a $2.4 million benefit, excluding a net tax benefit of $4.7 million, mainly due to one-time release of tax reserve and adjusting for net tax effects on one-time items, our non-GAAP tax expense for the quarter was $2.3 million.
Turning to the balance sheet, total cash, cash equivalent, and investments increased $16 million to $383.3 million at the end of the second quarter, which included $1.6 million of restricted cash. During the quarter we decrease inventory by about $23 million to $260.7 million. Weeks of inventory decreased about one week and are now about 19 weeks.
In the December quarter, we generated $41.9 million in cash from operating activities, mainly due to improved working capital. Cash capital expenditures for the quarter was $26.1 million or about 11.6% of revenue. Free cash flow was $15.9 million. Depreciation and amortization expense was $23.1 million, and stock-based compensation was $5.4 million.